Gastric cancer or gastroesophageal junction cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age range: 20 - 80 years old, gender not restricted; 2. Diagnosed with adenocarcinoma through tissue biopsy; 3. ECOG score: 0 - 2; 4. ASA classification: I - III; 5. Undergone radical surgery + D2 lymph node dissection; 6. Received either simple chemotherapy or chemotherapy combined with immunotherapy before the surgery, and the total treatment course was >= 2 cycles; 7. No distant metastasis was found before the surgery (M0).
Exclusion criteria
Exclusion criteria: 1. Preoperative radiotherapy, targeted therapy or neoadjuvant treatment were not determined; 2. Multiple lesions in the stomach were present; 3. Distal metastasis of gastric cancer (M1 stage) was detected preoperatively or intraoperatively, or positive results from abdominal implantation metastasis or abdominal exfoliated cell examination were found; 4. History of other malignant tumors within 5 years; 5. Emergency surgery or palliative surgery; 6. Key clinical data were missing (lymph node station information was not clearly recorded in the pathological report, preoperative treatment plan was not clearly recorded in the medical record, etc.), which prevented analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival rate without recurrence; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival ;Station 1–Station 12 lymph node metastasis rate;Index of lymph node treatment for each station;Pathological complete response rate; | — |
Countries
China
Contacts
Chinese Academy of Medical Sciences Cancer Hospital